Gruia Gabriela bought APRE
June 16, 2026 · Form 4 insider transaction
Gruia Gabriela bought 3,135 shares of Aprea Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
3,135
Price
$0.00
Total value
N/A
InsiderGruia Gabriela
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJune 16, 2026
Filing dateJune 17, 2026
Shares owned after4,180
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These shares represent restricted stock units which were granted on June 16, 2026, and which will vest and be settled in common stock on June 16, 2027, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.